BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 30537868)

  • 1. Glia-immune interactions post-ischemic stroke and potential therapies.
    Hersh J; Yang SH
    Exp Biol Med (Maywood); 2018 Dec; 243(17-18):1302-1312. PubMed ID: 30537868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolving role of neuro-immune interaction in brain repair after cerebral ischemic stroke.
    Wang X; Xuan W; Zhu ZY; Li Y; Zhu H; Zhu L; Fu DY; Yang LQ; Li PY; Yu WF
    CNS Neurosci Ther; 2018 Dec; 24(12):1100-1114. PubMed ID: 30350341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention.
    Ao LY; Yan YY; Zhou L; Li CY; Li WT; Fang WR; Li YM
    J Mol Neurosci; 2018 Nov; 66(3):342-355. PubMed ID: 30276612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocyte-derived interleukin-15 exacerbates ischemic brain injury via propagation of cellular immunity.
    Li M; Li Z; Yao Y; Jin WN; Wood K; Liu Q; Shi FD; Hao J
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):E396-E405. PubMed ID: 27994144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial Cells: Role of the Immune Response in Ischemic Stroke.
    Xu S; Lu J; Shao A; Zhang JH; Zhang J
    Front Immunol; 2020; 11():294. PubMed ID: 32174916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
    Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
    Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of σ1 and σ2 receptors by afobazole increases glial cell survival and prevents glial cell activation and nitrosative stress after ischemic stroke.
    Katnik C; Garcia A; Behensky AA; Yasny IE; Shuster AM; Seredenin SB; Petrov AV; Cuevas J
    J Neurochem; 2016 Nov; 139(3):497-509. PubMed ID: 27488244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral immune cells infiltrate into sites of secondary neurodegeneration after ischemic stroke.
    Jones KA; Maltby S; Plank MW; Kluge M; Nilsson M; Foster PS; Walker FR
    Brain Behav Immun; 2018 Jan; 67():299-307. PubMed ID: 28911981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pivotal role of innate myeloid cells in cerebral post-ischemic sterile inflammation.
    Tsuyama J; Nakamura A; Ooboshi H; Yoshimura A; Shichita T
    Semin Immunopathol; 2018 Nov; 40(6):523-538. PubMed ID: 30206661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term T cell responses in the brain after an ischemic stroke.
    Selvaraj UM; Stowe AM
    Discov Med; 2017 Dec; 24(134):323-333. PubMed ID: 29373810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Immune Interactions-Novel Emerging Options to Treat Acute Ischemic Brain Injury.
    Muhammad S; Chaudhry SR; Kahlert UD; Niemelä M; Hänggi D
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmented β2-adrenergic signaling dampens the neuroinflammatory response following ischemic stroke and increases stroke size.
    Lechtenberg KJ; Meyer ST; Doyle JB; Peterson TC; Buckwalter MS
    J Neuroinflammation; 2019 May; 16(1):112. PubMed ID: 31138227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged mice.
    Zhu W; Dotson AL; Libal NL; Lapato AS; Bodhankar S; Offner H; Alkayed NJ
    Neuroscience; 2015 Mar; 288():112-9. PubMed ID: 25556831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Involvement and Therapy Target of Immune Cells After Ischemic Stroke.
    Jian Z; Liu R; Zhu X; Smerin D; Zhong Y; Gu L; Fang W; Xiong X
    Front Immunol; 2019; 10():2167. PubMed ID: 31572378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke.
    Neumann J; Riek-Burchardt M; Herz J; Doeppner TR; König R; Hütten H; Etemire E; Männ L; Klingberg A; Fischer T; Görtler MW; Heinze HJ; Reichardt P; Schraven B; Hermann DM; Reymann KG; Gunzer M
    Acta Neuropathol; 2015 Feb; 129(2):259-77. PubMed ID: 25391494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
    Shekhar S; Cunningham MW; Pabbidi MR; Wang S; Booz GW; Fan F
    Eur J Pharmacol; 2018 Aug; 833():531-544. PubMed ID: 29935175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of microglia with infiltrating immune cells in the different phases of stroke.
    Berchtold D; Priller J; Meisel C; Meisel A
    Brain Pathol; 2020 Nov; 30(6):1208-1218. PubMed ID: 33058417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous Protection from Ischemic Brain Injury by Preconditioned Monocytes.
    Garcia-Bonilla L; Brea D; Benakis C; Lane DA; Murphy M; Moore J; Racchumi G; Jiang X; Iadecola C; Anrather J
    J Neurosci; 2018 Jul; 38(30):6722-6736. PubMed ID: 29946039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation, plasticity and real-time imaging after cerebral ischemia.
    Kriz J; Lalancette-Hébert M
    Acta Neuropathol; 2009 May; 117(5):497-509. PubMed ID: 19225790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets.
    Gu Y; Chen J; Shen J
    J Neuroimmune Pharmacol; 2014 Jun; 9(3):313-39. PubMed ID: 24562591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.